Previsioni di mercato dei servizi di farmacocinetica in America Centrale e Meridionale fino al 2031 - Analisi regionale - per tipo di farmaco (piccole molecole, grandi molecole e vaccini), tipo di servizio (studi ADME e umani preclinici, analisi e reporting PK/PD, simulazioni di dosaggio, analisi del rischio e altri), applicazione terapeutica (oncologia, malattie infettive, disturbi neurologici, malattie autoimmuni, disturbi ginecologici, malattie cardiovascolari, disturbi respiratori e altri) e utente finale (aziende farmaceutiche e biotecnologiche, organizzazioni di ricerca a contratto e altri)
L\'outsourcing dei servizi di farmacocinetica alle CRO alimenta il mercato dei servizi di farmacocinetica in America Centrale e Meridionale
L\'outsourcing dei servizi di farmacocinetica alle organizzazioni di ricerca a contratto (CRO) offre diversi vantaggi ai produttori di farmaci e agli sponsor. Possono operare in modo economicamente conveniente optando per questi servizi. Inoltre, possono concentrarsi sul lavoro flessibile e sulla scalabilità delle loro operazioni principali, oltre a ottenere tempi di consegna rapidi. L\'outsourcing aiuta le aziende farmaceutiche a concentrarsi sulla commercializzazione dei prodotti, implementando al contempo misure per lo sviluppo delle capacità, la riduzione dei costi e la gestione dei dati. Il processo di scoperta dei farmaci è complesso e qualsiasi errore o risultato falso può comportare costi significativi e ritardare il processo. Le CRO impiegano scienziati e ricercatori esperti che possiedono competenze in farmacocinetica e altri campi. Pertanto, forniscono alle aziende farmaceutiche l\'accesso alle loro competenze, eliminando così la necessità di investire nell\'assunzione di tale forza lavoro qualificata o di fornire formazione extra per costruirla. Pertanto, le piccole aziende con promettenti candidati farmaci ma risorse limitate e le grandi aziende coinvolte nella diversificazione delle loro operazioni stanno optando per servizi di ricerca clinica forniti da CRO ben organizzate, il che rafforza il mercato dei servizi di farmacocinetica.
Panoramica del mercato dei servizi di farmacocinetica in America Centrale e Meridionale
Il Brasile è una destinazione importante per le sperimentazioni cliniche. Secondo Clinical Trials Arena, nel 2021, il Brasile ha rappresentato l\'1,7% dell\'attività globale di sperimentazioni cliniche. A luglio 2022, Boston CRO ha acquisito Instituto Brasil de Pesquisa Clinica (IBPClin), con sede a Rio de Janeiro, come primo passo verso l\'implementazione del suo modello di fornitura di sperimentazioni cliniche decentralizzato in America Latina. Afferma di aver condotto più di 160 studi di ricerca sponsorizzati dall\'industria, arruolando più di 7.000 partecipanti in 12 stati brasiliani. IBPClin è il più grande centro di ricerca del Sud America. A marzo 2020, la Fondazione Fiocruz ha costruito un nuovo centro ospedaliero con l\'impegno di investire in sperimentazioni cliniche supportate dall\'Organizzazione mondiale della sanità (OMS). Il nuovo ospedale è stato progettato per ospitare la sperimentazione clinica Solidarity guidata da Fiocruz in Brasile, l\'iniziativa implementata in 18 ospedali in 12 stati del Brasile con il supporto del Dipartimento di scienza e tecnologia del Ministero della salute e coordinata da INI/Fiocruz. Pertanto, tali iniziative intraprese per lo sviluppo della ricerca clinica stimolano la crescita del mercato dei servizi di farmacocinetica in Brasile.
Ricavi e previsioni del mercato dei servizi di farmacocinetica in America Centrale e Meridionale fino al 2031 (milioni di $ USA)
Segmentazione del mercato dei servizi di farmacocinetica in America Centrale e Meridionale
Il mercato dei servizi di farmacocinetica in America Centrale e Meridionale è suddiviso in tipo di farmaco, tipo di servizio, applicazione terapeutica, utente finale e paese.
In base al tipo di farmaco, il mercato dei servizi di farmacocinetica in America Centrale e Meridionale è suddiviso in piccole molecole, grandi molecole e vaccini. Il segmento delle piccole molecole ha detenuto la quota di mercato maggiore nel 2023.
In termini di tipo di servizio, il mercato dei servizi di farmacocinetica in America Centrale e Meridionale è suddiviso in studi ADME preclinici e sull\'uomo, analisi e reporting PK/PD, simulazioni di dosaggio, analisi del rischio e altri. Il segmento ADME preclinico e studi sull\'uomo ha detenuto la quota di mercato più grande nel 2023.
Per applicazione terapeutica, il mercato dei servizi di farmacocinetica del Sud e Centro America è segmentato in oncologia, malattie infettive, disturbi neurologici, malattie autoimmuni, disturbi ginecologici, malattie cardiovascolari, disturbi respiratori e altri. Il segmento oncologico ha detenuto la quota di mercato più grande nel 2023.
Per utente finale, il mercato dei servizi di farmacocinetica del Sud e Centro America è segmentato in aziende farmaceutiche e biotecnologiche, organizzazioni di ricerca a contratto e altri. Il segmento delle organizzazioni di ricerca a contratto ha detenuto la quota di mercato più grande nel 2023.
Per paese, il mercato dei servizi di farmacocinetica del Sud e Centro America è segmentato in Brasile, Argentina e resto del Sud e Centro America. Il Brasile ha dominato la quota di mercato dei servizi di farmacocinetica del Sud e Centro America nel 2023.
Charles River Laboratories International Inc; Eurofins Scientific SE; Certara Inc.; Parexel International Corp; Thermo Fisher Scientific Inc.; Allucent; PACIFIC BIOLABS; e SGS SA sono alcune delle aziende leader che operano nel mercato dei servizi di farmacocinetica in America Centrale e Meridionale.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Pharmacokinetics Services Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Chronic and Infectious Diseases
4.1.2 Expanding Range of Application of Pharmacokinetic Studies
4.1.3 Outsourcing of Pharmacokinetics Services to CROs
4.2 Market Restraints
4.2.1 Limited Reach of Pharmacokinetics Service Providers in Emerging Countries
4.3 Market Opportunities
4.3.1 Increasing Adoption of In-Vivo and In-Vitro Models for Understanding Variability in Pharmacokinetics
4.4 Future Trend
4.4.1 Increasing Adoption of Big Data Analytics in Pharmacokinetics Services
4.5 Impact of Drivers and Restraints:
5. Pharmacokinetics Services Market - South & Central America Analysis
5.1 South & Central America Pharmacokinetics Services Market Overview
5.2 South & Central America Pharmacokinetics Services Market Revenue (US$ Million), 2021-2031
6. South & Central America Pharmacokinetics Services Market Analysis - by Drug Type
6.1 Overview
6.2 Small Molecule
6.2.1 Overview
6.2.2 Small Molecule: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
6.3 Large Molecule
6.3.1 Overview
6.3.2 Large Molecule: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
6.4 Vaccines
6.4.1 Overview
6.4.2 Vaccines: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7. South & Central America Pharmacokinetics Services Market Analysis - by Service Type
7.1 Overview
7.2 Pre-Clinical ADME and Human Studies
7.2.1 Overview
7.2.2 Pre-Clinical ADME and Human Studies: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7.3 PK/PD Analysis and Reporting
7.3.1 Overview
7.3.2 PK/PD Analysis and Reporting: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Dosing Simulations
7.4.1 Overview
7.4.2 Dosing Simulations: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Risk Analysis
7.5.1 Overview
7.5.2 Risk Analysis: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8. South & Central America Pharmacokinetics Services Market Analysis - by Therapeutic Application
8.1 Oncology
8.1.1 Overview
8.1.2 Oncology: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Infectious Diseases
8.2.1 Overview
8.2.2 Infectious Diseases: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Neurological Disorders
8.3.1 Overview
8.3.2 Neurological Disorders: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Autoimmune Diseases
8.4.1 Overview
8.4.2 Autoimmune Diseases: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Gynecological Disorders
8.5.1 Overview
8.5.2 Gynecological Disorders: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Cardiovascular Diseases
8.6.1 Overview
8.6.2 Cardiovascular Diseases: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.7 Respiratory Disorders
8.7.1 Overview
8.7.2 Respiratory Disorders: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9. South & Central America Pharmacokinetics Services Market Analysis - by End User
9.1 Pharmaceutical and Biotechnology Companies
9.1.1 Overview
9.1.2 Pharmaceutical and Biotechnology Companies: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Contract Research Organization
9.2.1 Overview
9.2.2 Contract Research Organization: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10. South & Central America Pharmacokinetics Services Market - Country Analysis
10.1 South & Central America
10.1.1 South & Central America Pharmacokinetics Services Market Breakdown by Countries, 2023 and 2031 (%)
10.1.1.1 Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.1.3 Brazil: South & Central America Pharmacokinetics Services Market Breakdown, by Drug Type
10.1.1.1.4 Brazil: South & Central America Pharmacokinetics Services Market Breakdown, by Service Type
10.1.1.1.5 Brazil: South & Central America Pharmacokinetics Services Market Breakdown, by Therapeutic Application
10.1.1.1.6 Brazil: South & Central America Pharmacokinetics Services Market Breakdown, by End User
10.1.1.2 Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.2.3 Argentina: South & Central America Pharmacokinetics Services Market Breakdown, by Drug Type
10.1.1.2.4 Argentina: South & Central America Pharmacokinetics Services Market Breakdown, by Service Type
10.1.1.2.5 Argentina: South & Central America Pharmacokinetics Services Market Breakdown, by Therapeutic Application
10.1.1.2.6 Argentina: South & Central America Pharmacokinetics Services Market Breakdown, by End User
10.1.1.3 Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.3.3 Rest of South & Central America: South & Central America Pharmacokinetics Services Market Breakdown, by Drug Type
10.1.1.3.4 Rest of South & Central America: South & Central America Pharmacokinetics Services Market Breakdown, by Service Type
10.1.1.3.5 Rest of South & Central America: South & Central America Pharmacokinetics Services Market Breakdown, by Therapeutic Application
10.1.1.3.6 Rest of South & Central America: South & Central America Pharmacokinetics Services Market Breakdown, by End User
11. Company Profile
11.1 Charles River Laboratories International Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Eurofins Scientific SE
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Certara Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Parexel International Corp
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Thermo Fisher Scientific Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Allucent
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 PACIFIC BIOLABS
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 SGS SA
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms for Pharmacokinetic Services Market
?
List of Tables
Table 1. South & Central America Pharmacokinetics Services Market Segmentation
Table 2. Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Drug Type
Table 3. Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Service Type
Table 4. Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Therapeutic Application
Table 5. Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 6. Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Drug Type
Table 7. Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Service Type
Table 8. Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Therapeutic Application
Table 9. Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 10. Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Drug Type
Table 11. Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Service Type
Table 12. Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Therapeutic Application
Table 13. Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 14. Glossary of Terms
?
List of Figures
Figure 1. South & Central America Pharmacokinetics Services Market Segmentation, by Country
Figure 2. South & Central America Pharmacokinetics Services Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Pharmacokinetics Services Market Revenue (US$ Million), 2021-2031
Figure 5. South & Central America Pharmacokinetics Services Market Share (%) - by Drug Type (2023 and 2031)
Figure 6. Small Molecule: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Large Molecule: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Vaccines: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. South & Central America Pharmacokinetics Services Market Share (%) - by Service Type (2023 and 2031)
Figure 10. Pre-Clinical ADME and Human Studies: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. PK/PD Analysis and Reporting: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Dosing Simulations: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Risk Analysis: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Others: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. South & Central America Pharmacokinetics Services Market Share (%) - by Therapeutic Application (2023 and 2031)
Figure 16. Oncology: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Infectious Diseases: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Neurological Disorders: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Autoimmune Diseases: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Gynecological Disorders: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 21. Cardiovascular Diseases: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Respiratory Disorders: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. South & Central America Pharmacokinetics Services Market Share (%) - by End User (2023 and 2031)
Figure 25. Pharmaceutical and Biotechnology Companies: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 26. Contract Research Organization: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. Others: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. South & Central America Pharmacokinetics Services Market by Key Countries - Revenue (2023) (US$ Million)
Figure 29. Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 30. Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 31. Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
- Charles River Laboratories International Inc
- Eurofins Scientific SE
- Certara Inc.
- Parexel International Corp
- Thermo Fisher Scientific Inc.
- Allucent
- PACIFIC BIOLABS
- SGS SA
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America pharmacokinetics services market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America pharmacokinetics services market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America pharmacokinetics services market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.